Dissecting the phenotypes of Plk1 inhibition in cancer cells using novel kinase inhibitory chemical CBB2001

Rongfeng Lan(Shenzhen University Health Science Center), Hui Zhang(American Health Network), Zhen Yang(Chongqing University), Fei Lu(Kunming Medical University), Jing Wang(Sun Yat-sen University), Xiao‐Ming Zhang(Chinese Academy of Agricultural Mechanization Sciences), Yanchao Wang(Jilin University), Feng Yin(Chinese University of Hong Kong, Shenzhen), Yuanhua Ding(Pfizer (United States)), Jun Xu(University of California San Diego), Guimiao Lin(Shenzhen University Health Science Center), Jianxian Gong(Peking University)
Laboratory Investigation
August 13, 2012
10.1038/labinvest.2012.114
Cited by 19

Related Papers

IEEE TRANSACTIONS ON CIRCUITS AND SYSTEMS—I: REGULAR PAPERS
|IEEE Transactions on Circuits and Systems I Regular Papers|2022|347
The Fibrillin‐1/VEGFR2/STAT2 signaling axis promotes chemoresistance via modulating glycolysis and angiogenesis in ovarian cancer organoids and cells
|癌症：英文版|2022|172
Black phosphorus quantum dot based novel siRNA delivery systems in human pluripotent teratoma PA-1 cells
|Journal of Materials Chemistry B|2017|167
Interrogating glioma-M2 macrophage interactions identifies Gal-9/Tim-3 as a viable target against <i>PTEN</i> -null glioblastoma
|Science Advances|2022|141
Low-Grade Astrocytoma Mutations in IDH1, P53, and ATRX Cooperate to Block Differentiation of Human Neural Stem Cells via Repression of SOX2
|Cell Reports|2017|129